Finance

Lists
RHHVF:OTCMKTS
Roche Holding AG Genussscheine
US$434,14
+1,96%
(+8,36) 1D
9 ຕ.ລ., 16 ໂມງ 0 ນາທີ 00 ວິນາທີ GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RHHVF...
Open
US$433,82
High
US$434,14
Low
US$427,10
Mkt. cap
349,40 ຕື້
Avg. vol.
4,75 ພັນ
Volume
283,00
52-wk high
US$490,33
52-wk low
US$318,81
Beta
0,51
Shares outstanding
702,56 ລ້ານ
No. of employees
113 ພັນ
Open
US$433,82
High
US$434,14
Low
US$427,10
Mkt. cap
349,40 ຕື້
Avg. vol.
4,75 ພັນ
Volume
283,00
52-wk high
US$490,33
52-wk low
US$318,81
Beta
0,51
Shares outstanding
702,56 ລ້ານ
No. of employees
113 ພັນ
News stories
From web sources and news partners
Profile
F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel. Roche is the fifth-largest pharmaceutical company in the world by revenue and the leading provider of cancer treatments globally. In 2023, the company’s seat in Forbes Global 2000 was 76. The company owns the American biotechnology company Genentech, which is a wholly owned independent subsidiary, and the Japanese biotechnology company Chugai Pharmaceuticals, as well as the United States–based companies Ventana and Foundation Medicine. Roche's revenues during fiscal year 2020, were 58.32 billion Swiss francs. Descendants of the founding Hoffmann and Oeri families own slightly over half of the bearer shares with voting rights, with Swiss pharma firm Novartis owning a further third of its shares until 2021. F. Hoffmann-La Roche is a full member of the European Federation of Pharmaceutical Industries and Associations. Wikipedia
About Roche Holding AG Genussscheine
CEOThomas Schinecker
Employees113 ພັນ
Founded1 ຕ.ລ. 1896
Headquartersບາເຊວ, Basel City, ສະວິດເຊີແລນ
SectorPharmaceutical industry
Websiteroche.com
Previous reportsAll values in CHF
Loading Previous Earnings...
Revenue
Net income
All values in CHF
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
ມິ.ຖ. 2026
Revenue
15,75 ຕື້
15,75 ຕື້
15,73 ຕື້
15,73 ຕື້
Cost of goods sold
4,21 ຕື້
4,21 ຕື້
3,93 ຕື້
3,93 ຕື້
Cost of revenue
4,21 ຕື້
4,21 ຕື້
3,93 ຕື້
3,93 ຕື້
Research and development expenses
3,15 ຕື້
3,15 ຕື້
2,99 ຕື້
2,99 ຕື້
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,59 ຕື້
3,59 ຕື້
3,22 ຕື້
3,22 ຕື້
Operating expense
6,82 ຕື້
6,82 ຕື້
6,11 ຕື້
6,11 ຕື້
Total operating expenses
11,03 ຕື້
11,03 ຕື້
10,03 ຕື້
10,03 ຕື້
Operating income
4,72 ຕື້
4,72 ຕື້
5,69 ຕື້
5,69 ຕື້
Other non operating income
-10,00 ລ້ານ
-10,00 ລ້ານ
-15,00 ລ້ານ
-15,00 ລ້ານ
EBT including unusual items
3,69 ຕື້
3,69 ຕື້
4,49 ຕື້
4,49 ຕື້
EBT excluding unusual items
4,37 ຕື້
4,37 ຕື້
5,38 ຕື້
5,38 ຕື້
Income tax expense
709,00 ລ້ານ
709,00 ລ້ານ
824,00 ລ້ານ
824,00 ລ້ານ
Effective tax rate
19,20%
19,20%
18,37%
18,37%
Other operating expenses
77,50 ລ້ານ
77,50 ລ້ານ
-99,00 ລ້ານ
-99,00 ລ້ານ
Net income
2,74 ຕື້
2,74 ຕື້
3,44 ຕື້
3,44 ຕື້
Net profit margin
17,36%
17,36%
21,85%
21,85%
Earnings per share
-
-
-
-
Interest and investment income
45,00 ລ້ານ
45,00 ລ້ານ
43,50 ລ້ານ
43,50 ລ້ານ
Interest expense
-289,50 ລ້ານ
-289,50 ລ້ານ
-282,00 ລ້ານ
-282,00 ລ້ານ
Net interest expenses
-244,50 ລ້ານ
-244,50 ລ້ານ
-238,50 ລ້ານ
-238,50 ລ້ານ
Depreciation and amortization charges
-
-
-
-
EBITDA
5,50 ຕື້
5,50 ຕື້
6,48 ຕື້
6,48 ຕື້
Gain or loss from assets sale
-21,50 ລ້ານ
-21,50 ລ້ານ
-2,50 ລ້ານ
-2,50 ລ້ານ
AI content may include mistakes. Learn more
ແອັບຂອງ Google